Studies have shown that VPA could significantly inhibit the expression of vascular endothelial growth factor (VEGF) and MMP9, promote the expression of E-cadherin, and inhibit the migration and invasion of ovarian cancer cells in vitro and in vivo [141]. This evidence concerns the gene VEGFA and ovarian carcinoma.